Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: A nationwide cohort study

BMC Cancer

Volumn 17, Issue 1, 2017, Pages

  Song, Huan ^a   Fang, Fang ^a   Valdimarsdóttir, Unnur ^a,b,c   Lu, Donghao ^a   Andersson, Therese M L ^a,d   Hultman, Christina ^a   Ye, Weimi ^a   Lundell, Lars ^e   Johansson, Jan ^f   Nilsson, Magnus ^e   Lindblad, Mats ^e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF ICELAND   (Iceland)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer treatment; Cohort study; Esophageal cancer; Gastric cancer; Mental disorder; Waiting time

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT;

AGE DISTRIBUTION; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER REGISTRY; CANCER THERAPY; CLINICAL DECISION MAKING; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DEPRESSION; EDUCATIONAL STATUS; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HAZARD RATIO; HEALTH STATUS; HOSPITALIZATION; HUMAN; ICD-10-PCS; INCIDENCE; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH CARE; ONSET AGE; OVERALL SURVIVAL; PRESCRIPTION; PSYCHIATRIC TREATMENT; RISK ASSESSMENT; SEX DIFFERENCE; STOMACH CANCER; TREATMENT DECISION; VERY ELDERLY; WAITING TIME; WELLBEING; CANCER STAGING; COMPLICATION; ESOPHAGEAL NEOPLASMS; MALE; MENTAL DISORDERS; PROGNOSIS; PSYCHOLOGY; REGISTER; STOMACH NEOPLASMS; SWEDEN; TIME TO TREATMENT;

AGED; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MENTAL DISORDERS; MENTAL HEALTH; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; STOMACH NEOPLASMS; SWEDEN; TIME-TO-TREATMENT;

EID: 85008235638     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-016-3013-7     Document Type: Article

References (37)

1. Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077-9.
2. Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17(7):1721-4.
3. Matsuo K, Opper NR, Ciccone MA, Garcia J, Tierney KE, Baba T, Muderspach LI, Roman LD. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer association between tumor characteristics and survival outcome. Obstet Gynecol. 2015;125(2):424-33.
4. Comber H, Cronin DP, Deady S, Lorcain PO, Riordan P. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir Med J. 2005;98(8):238-9.
5. Department of Health. The NHS cancer plan. Department of Health, London; 2000.
6. Raptis DA, Fessas C, Belasyse-Smith P, Kurzawinski TR. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer. Surgeon. 2010;8(5):239-46.
7. Spahos T, Hindmarsh A, Cameron E, Tighe MR, Igali L, Pearson D, Rhodes M, Lewis MP. Endoscopy waiting times and impact of the two week wait scheme on diagnosis and outcome of upper gastrointestinal cancer. Postgrad Med J. 2005;81(961):728-30.
8. Sharpe D, Williams RN, Ubhi SS, Sutton CD, Bowrey DJ. The "two-week wait" referral pathway allows prompt treatment but does not improve outcome for patients with oesophago-gastric cancer. Eur J Surg Oncol. 2010;36(10):977-81.
9. Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160-74.
10. Lu D, Andersson TM, Fall K, Hultman CM, Czene K, Valdimarsdottir U, Fang F. Clinical Diagnosis of Mental Disorders Immediately Before and After Cancer Diagnosis: A Nationwide Matched Cohort Study in Sweden. JAMA Oncol. 2016;2(9):1188-96.
11. Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ. Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol. 2009;27(28):4671-8.
12. Bilimoria KY, Ko CY, Tomlinson JS, Stewart AK, Talamonti MS, Hynes DL, Winchester DP, Bentrem DJ. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253(4):779-85.
13. Liederbach E, Sisco M, Wang C, Pesce C, Sharpe S, Winchester DJ, Yao K. Wait times for breast surgical operations, 2003-2011: a report from the National Cancer Data Base. Ann Surg Oncol. 2015;22(3):899-907.
14. Linder G, Lindblad M, Djerf P, Elbe P, Johansson J, Lundell L, Hedberg J. Validation of data quality in the Swedish National Register for Oesophageal and Gastric Cancer. Br J Surg. 2016;103(10):1326-35.
15. Guo Z, Gill TM, Allore HG. Modeling repeated time-to-event health conditions with discontinuous risk intervals. An example of a longitudinal study of functional disability among older persons. Methods Inf Med. 2008;47(2):107-16.
16. Visser E, Leeftink AG, van Rossum PS, Siesling S, van Hillegersberg R, Ruurda JP. Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer. Ann Surg Oncol. 2016;23(8):2679-89.
17. Fassbender K, Walter S, Liu Y, Muehlhauser F, Ragoschke A, Kuehl S, Mielke O. "Mobile stroke unit" for hyperacute stroke treatment. Stroke. 2003;34(6):e44.
18. Raghavan R, Benzaquen BS, Rudski L. Timing of bypass surgery in stable patients after acute myocardial infarction. Can J Cardiol. 2007;23(12):976-82.
19. Helewa RM, Turner D, Park J, Wirtzfeld D, Czaykowski P, Hochman D, Singh H, Shu E, Mckay A. Longer waiting times for patients undergoing colorectal cancer surgery are not associated with decreased survival. J Surg Oncol. 2013;108(6):378-84.
20. Coughlin S, Plourde M, Guidolin K, Fortin D, Frechette E, Malthaner R, Inculet R. Is it safe to wait? The effect of surgical wait time on survival in patients with non-small cell lung cancer. Can J Surg. 2015;58(6):414-8.
21. Sanjeevi S, Ivanics T, Lundell L, Kartalis N, Andren-Sandberg A, Blomberg J, Del Chiaro M, Ansorge C. Impact of delay between imaging and treatment in patients with potentially curable pancreatic cancer. Br J Surg. 2016;103(3):267-75.
22. Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, Patel SA, Boraas M, Chang EI, Topham NS, et al. Time to surgery and breast cancer survival in the united states. JAMA Oncol. 2016;2(3):330-9.
23. van Harten MC, Hoebers FJ, Kross KW, van Werkhoven ED, van den Brekel MW, van Dijk BA. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol. 2015;51(3):272-8.
24. Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, Flieder DB, Ridge JA. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34(2):169-78.
25. Elit LM, O'Leary EM, Pond GR, Seow HY. Impact of wait times on survival for women with uterine cancer. J Clin Oncol. 2014;32(1):27-33.
26. Drageset S, Lindstrom TC, Giske T, Underlid K. Being in suspense: women's experiences awaiting breast cancer surgery. J Adv Nurs. 2011;67(9):1941-51.
27. Lally RM. Acclimating to breast cancer a process of maintaining self-integrity in the pretreatment period. Cancer Nurs. 2010;33(4):268-79.
28. Henselmans I, Sanderman R, Smink A, Ranchor AV, de Vries J. Waiting times in breast disease clinics and psychological well-being: speedy care is better care. Ned Tijdschr Geneeskd. 2010;154:B491.
29. McConnell YJ, Inglis K, Porter GA. Timely access and quality of care in colorectal cancer: are they related? Int J Qual Health Care. 2010;22(3):219-28.
30. Porter G, Urquhart R, Kendell C, Bu J, McConnell Y, Grunfeld E. Timely access and quality of care in colorectal cancer: a population-based cohort study using administrative data. BMC Res Notes. 2013;6:355.
31. Guan NC, Termorshuizen F, Laan W, Smeets HM, Zainal NZ, Kahn RS, De Wit NJ, Boks MP. Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer. Soc Psychiatry Psychiatr Epidemiol. 2013;48(8):1289-95.
32. Ishikawa H, Yasunaga H, Matsui H, Fushimi K, Kawakami N. Differences in cancer stage, treatment and in-hospital mortality between patients with and without schizophrenia: retrospective matched-pair cohort study. Br J Psychiatry. 2016;208(3):239-44.
33. Kisely S, Crowe E, Lawrence D. Cancer-related mortality in people with mental illness. JAMA Psychiat. 2013;70(2):209-17.
34. O'Rourke RW, Diggs BS, Spight DH, Robinson J, Elder KA, Andrus J, Thomas CR, Hunter JG, Jobe BA. Psychiatric illness delays diagnosis of esophageal cancer. Dis Esophagus. 2008;21(5):416-21.
35. Chang CK, Hayes RD, Broadbent MT, Hotopf M, Davies E, Møller H, Stewart R. A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival. BMJ Open. 2014;4(1):e004295.
36. He W, Fang F, Varnum C, Eriksson M, Hall P, Czene K. Predictors of discontinuation of adjuvant hormone therapy in patients with breast cancer. J Clin Oncol. 2015;33(20):2262-9.
37. Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CLM. The prevalence of psychiatric-disorders among cancer-patients. JAMA. 1983;249(6):751-7.